AL01211

AL01211 · AceLink Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL01211, covering 2024-07-30 to 2024-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease [Phase 2]

See pricing